Cargando…
Peroxisome Proliferator-Activated Receptor Agonists: Do They Increase Cardiovascular Risk?
Cardiovascular disease is a major cause of morbidity and mortality among people with type 2 diabetes mellitus. The peroxisome proliferator-activated receptor (PPAR) agonists have a significant role on glucose and fat metabolism. Thiazolidinediones (TZDs) are predominantly PPARγ agonists, and their p...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2729049/ https://www.ncbi.nlm.nih.gov/pubmed/19696948 http://dx.doi.org/10.1155/2009/460764 |